scholarly article | Q13442814 |
P50 | author | Barbara Rath | Q79969103 |
Ulrich Heininger | Q102068710 | ||
P2093 | author name string | Manya Magnus | |
P2860 | cites work | The development of standardized case definitions and guidelines for adverse events following immunization | Q80074697 |
Prediction rule for bacterial meningitis in children | Q80171849 | ||
Prediction rules for bacterial meningitis | Q80783893 | ||
Haemophilus influenzae type B meningitis among children in Hanoi, Vietnam: epidemiologic patterns and estimates of H. Influenzae type B disease burden | Q82767283 | ||
Neonatal meningitis: what is the correlation among cerebrospinal fluid cultures, blood cultures, and cerebrospinal fluid parameters? | Q83058115 | ||
Diagnostic value of immature neutrophils (bands) in the cerebrospinal fluid of children with cerebrospinal fluid pleocytosis | Q83853722 | ||
Assessment of current diagnostic criteria for Guillain-Barré syndrome | Q22252936 | ||
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” | Q22252938 | ||
ADEM: distinct disease or part of the MS spectrum? | Q28190836 | ||
Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative | Q30447885 | ||
Acute intussusception in infants and children as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation | Q30540815 | ||
Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients | Q30652840 | ||
The Brighton Collaboration: enhancing comparability of vaccine safety data | Q30804369 | ||
Fever as an adverse event following immunization: case definition and guidelines of data collection, analysis, and presentation | Q30890095 | ||
Swelling at or near injection site: case definition and guidelines for collection, analysis and presentation of immunization safety data | Q31114573 | ||
Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data | Q31115845 | ||
Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data | Q31116047 | ||
The diagnostic accuracy of Kernig's sign, Brudzinski's sign, and nuchal rigidity in adults with suspected meningitis | Q33959643 | ||
Revised diagnostic criteria for neuromyelitis optica | Q34529345 | ||
Sensitivity and specificity should be de-emphasized in diagnostic accuracy studies | Q35155689 | ||
Factors influencing PCR detection of viruses in cerebrospinal fluid of patients with suspected CNS infections | Q35483682 | ||
Comparative accuracy: assessing new tests against existing diagnostic pathways | Q36468809 | ||
Macrophage migration inhibitory factor in cerebrospinal fluid from patients with central nervous system infection | Q37279929 | ||
Clinical decision rules for evaluating meningitis in children. | Q37452663 | ||
Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa. | Q38905491 | ||
Development and validation of a multivariable predictive model to distinguish bacterial from aseptic meningitis in children in the post-Haemophilus influenzae era. | Q39632289 | ||
Evaluation of the Brighton Collaboration case definition of acute intussusception during active surveillance | Q40381108 | ||
A season of aseptic meningitis in Germany: epidemiologic, clinical and diagnostic aspects | Q40568996 | ||
Outbreak of aseptic meningitis associated with echovirus 13. | Q40570578 | ||
Acute meningitis with a negative Gram's stain: clinical and management outcomes in 171 episodes | Q40676080 | ||
Outpatient management without antibiotics of fever in selected infants | Q40710152 | ||
Differentiation of aseptic and bacterial meningitis in postoperative neurosurgical patients | Q40782208 | ||
Management of bacterial meningitis: 1998. | Q41724515 | ||
Accuracy of clinical presentation for differentiating bacterial from viral meningitis in adults: a multivariate approach | Q43854367 | ||
Validation of a diagnosis model for differentiating bacterial from viral meningitis in infants and children under 3.5 years of age. | Q44249184 | ||
Prospective validation of a clinical prediction model for Lyme meningitis in children | Q45026806 | ||
Encephalitis and aseptic meningitis, Olmsted County, Minnesota, 1950-1981: I. Epidemiology | Q46747148 | ||
Performance of the Brighton collaboration case definition for hypotonic-hyporesponsive episode (HHE) on reported collapse reactions following infant vaccinations in the Netherlands | Q64130238 | ||
High agreement but low kappa: I. The problems of two paradoxes | Q68803935 | ||
Multivariate approach to differential diagnosis of acute meningitis | Q71994443 | ||
Cerebrospinal fluid pleocytosis and prognosis in invasive meningococcal disease in children | Q77513505 | ||
P433 | issue | 19 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | meningitis | Q48143 |
acute disseminated encephalomyelitis | Q424242 | ||
myelitis | Q551085 | ||
collaboration | Q1145523 | ||
aseptic meningitis | Q4804182 | ||
P1104 | number of pages | 8 | |
P304 | page(s) | 3488-3495 | |
P577 | publication date | 2010-03-01 | |
P1433 | published in | Vaccine | Q7907941 |
P1476 | title | Evaluating the Brighton Collaboration case definitions, aseptic meningitis, encephalitis, myelitis, and acute disseminated encephalomyelitis, by systematic analysis of 255 clinical cases | |
P478 | volume | 28 |
Q50682460 | Awareness and utilization of reporting pathways for adverse events following immunization: online survey among pediatricians in Russia and Germany. |
Q90140950 | Central nervous system (CNS) enterovirus infections: A single center retrospective study on clinical features, diagnostic studies, and outcome |
Q36645032 | Enabling Precision Medicine With Digital Case Classification at the Point-of-Care. |
Q90248391 | Immunization in pregnancy safety surveillance in low and middle-income countries- field performance and validation of novel case definitions |
Q39650695 | Innovative Digital Tools and Surveillance Systems for the Timely Detection of Adverse Events at the Point of Care: A Proof-of-Concept Study |
Q91227810 | Vaccination-associated acute disseminated encephalomyelitis |
Search more.